Cargando…

Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial

BACKGROUND: Based on the neuroinflammation hypothesis in schizophrenia and known anti-inflammatory effects of berberine, the aim of the present study is to investigate the efficacy of berberine in treating negative symptoms and cognitive deficits in adult patients with chronic schizophrenia. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pu, Zhengping, Wen, Hui, Jiang, Hongxia, Hou, Qingmei, Yan, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108529/ https://www.ncbi.nlm.nih.gov/pubmed/37069570 http://dx.doi.org/10.1186/s13020-023-00746-4

Ejemplares similares

Management of cognitive and negative symptoms in schizophrenia
por: Maroney, Megan
Publicado: (2022)

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
por: Vasiliu, O.
Publicado: (2022)

NEGATIVE SYMPTOMS AND NEGATIVE SCHIZOPHRENIA
por: Chaturvedi, S.K., et al.
Publicado: (1984)

Therapeutic effect of qinghuanling on negative symptoms and cognitive function of schizophrenia
por: Zhang, Y., et al.
Publicado: (2021)

Negative symptoms in schizophrenia
por: Mitra, Sayantanava, et al.
Publicado: (2016)

Mindfulness-based intervention improves residual negative symptoms and cognitive impairment in schizophrenia: a randomized controlled follow-up study
por: Shen, Hui, et al.
Publicado: (2023)

Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
por: Li, Zheng, et al.
Publicado: (2014)

Berberine exerts an anti-inflammatory role in ocular Behcet's disease
por: Yang, Yan, et al.
Publicado: (2017)

Acetyl-L-Carnitine as An Add-On Therapy for Negative and Cognitive Symptoms of Schizophrenia: A Randomized Control Trial
por: kulkarni, shalmali, et al.
Publicado: (2022)

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms
por: Urban-Kowalczyk, Małgorzata, et al.
Publicado: (2015)

Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia
por: Wu, Qiongqiong, et al.
Publicado: (2021)

Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms
por: García-Portilla, María Paz, et al.
Publicado: (2021)

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
por: Lu, Zengsheng, et al.
Publicado: (2020)

NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION
por: Chaturvedi, S.K., et al.
Publicado: (1985)

The efficacy of homestyle rehabilitation on negative symptoms in chronic schizophrenia: A randomized controlled trial
por: Chai, Jiabao, et al.
Publicado: (2023)

Negative symptom dimensions and social functioning in Chinese patients with schizophrenia
por: Gao, Tianqi, et al.
Publicado: (2022)

PM521. Relationship between Negative Symptoms and Social Cognition in Patient with Schizophrenia
por: Hyun, Jiewon, et al.
Publicado: (2016)

Cognitive dysfunction in first-episode schizophrenia and its correlation with negative symptoms and insight
por: Bhat, Pookala Shivaram, et al.
Publicado: (2021)

Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients
por: Kalisova, L., et al.
Publicado: (2023)

The interaction of lipids and inflammatory markers predict negative symptom severity in patients with schizophrenia
por: Goldsmith, David R., et al.
Publicado: (2021)

Cognitive and negative symptoms in schizophrenia with L‐Carnosine adjuvant therapy – A randomized double‐blind placebo‐controlled study
por: Tharoor, Hema, et al.
Publicado: (2023)

Anti-Inflammatory Effects of Berberine Hydrochloride in an LPS-Induced Murine Model of Mastitis
por: Wang, Xichun, et al.
Publicado: (2018)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
por: Zhuo, Kaiming, et al.
Publicado: (2019)

Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)

The Effects of Bupropion on Negative Symptoms in Schizophrenia
por: Yassini, Mojtaba, et al.
Publicado: (2014)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Treating Negative Symptoms in Schizophrenia: an Update
por: Remington, Gary, et al.
Publicado: (2016)

Primary and Secondary Negative Symptoms in Schizophrenia
por: Mosolov, Sergey N., et al.
Publicado: (2022)

MDMA for the Treatment of Negative Symptoms in Schizophrenia
por: Arnovitz, Mitchell D., et al.
Publicado: (2022)

Predictive biomarkers for negative symptoms in schizophrenia
por: Cakici, N., et al.
Publicado: (2021)

Marker of schizophrenia with enduring negative symptoms
por: Dmitrieva, E., et al.
Publicado: (2022)

Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia
por: Zhou, Qi, et al.
Publicado: (2023)

F83. INVESTIGATING THE RELATIONSHIP BETWEEN NEGATIVE SYMPTOM PROFILE AND COGNITIVE FUNCTION IN SCHIZOPHRENIA
por: Yolland, Caitlin, et al.
Publicado: (2018)

The Cognitive Model of Negative Symptoms in Schizophrenia: A Hierarchical Component Model With PLS-SEM
por: Ebrahimi, Ali, et al.
Publicado: (2021)

2329 Associations between inflammatory markers and negative symptoms in individuals with schizophrenia: Converging evidence
por: Goldsmith, David, et al.
Publicado: (2018)

M44. COGNITIVE REMEDIATION AND PHYSICAL EXERCISE EFFECTS ON NEGATIVE SYMPTOMS AND FUNCTIONALITY IN PATIENTS WITH SCHIZOPHRENIA: A RANDOMIZED CONTROLLED TRIAL
por: Mane, Anna, et al.
Publicado: (2020)

Adipose Tissue SIRT1 Regulates Insulin Sensitizing and Anti-Inflammatory Effects of Berberine
por: Shan, Yun, et al.
Publicado: (2020)

Anti‐inflammatory and immune‐modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation
por: Ehteshamfar, Seyed‐Morteza, et al.
Publicado: (2020)

Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
por: Limosin, Frédéric
Publicado: (2014)

A Bioecosystem Theory of Negative Symptoms in Schizophrenia
por: Strauss, Gregory P.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r9oh3e7328rv19hfsm0k4t5tn7